Literature DB >> 33518683

Complete Deletion of Slc52a2 Causes Embryonic Lethality in Mice.

Congyun Jin1,2, Yoshihiro Matsui1,2, Atsushi Yonezawa1,2, Satoshi Imai1, Takashi Ogihara1,2, Kotaro Itohara1, Shunsaku Nakagawa1, Takayuki Nakagawa1, Kazuo Matsubara1.   

Abstract

Riboflavin (vitamin B2) plays an important role in cellular growth and function. Riboflavin transporter 2 (RFVT2) is widely expressed in several tissues, especially in the brain and salivary glands, and plays an important role in the tissue disruption of riboflavin. During the last 10 years, mutations in SLC52A2 have been documented in patients with a rare neurological disorder known as Brown-Vialetto-Van Laere syndrome. However, no suitable animal model of this disease has been reported. Here, we aimed to clarify the physiological role of RFVT2 using Slc52a2-mutant mice. The appearance, body weight, and plasma riboflavin concentration of Slc52a2 heterozygous mutant (Slc52a2+/-) mice were similar to those of wild-type (WT) mice. However, intercrossing between Slc52a2+/- mice failed to generate Slc52a2 homozygous mutant (Slc52a2-/-) mice. This suggested that Slc52a2 gene deficiency results in early embryonic lethality. Our findings suggested that RFVT2 is essential for growth and development, and its deletion may influence embryonic survival.

Entities:  

Keywords:  embryonic lethality; mouse model; riboflavin transporter 2

Year:  2021        PMID: 33518683     DOI: 10.1248/bpb.b20-00751

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  1 in total

1.  First report of paternal uniparental disomy of chromosome 8 with SLC52A2 mutation in Brown-vialetto-van laere syndrome type 2 and an analysis of genotype-phenotype correlations.

Authors:  Siyu Zhao; Fengyu Che; Le Yang; Yanyan Zheng; Dong Wang; Ying Yang; Yan Wang
Journal:  Front Genet       Date:  2022-09-15       Impact factor: 4.772

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.